{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:42:55Z","timestamp":1788460975704,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL117933"],"award-info":[{"award-number":["R01HL117933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL144558"],"award-info":[{"award-number":["R01HL144558"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.atherosclerosis.2024.118565","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T09:20:55Z","timestamp":1723540855000},"page":"118565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Relationships between HDL subpopulation proteome and HDL function in overweight\/obese people with and without coronary heart disease"],"prefix":"10.1016","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-6606","authenticated-orcid":false,"given":"Tomas","family":"Vaisar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Babenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin V.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Niisuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela F.","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118565_bib1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2023.01.015","article-title":"Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: the pooling project","volume":"367","author":"Schaefer","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib4","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2019.01.001","article-title":"HDL cholesterol and ASCVD risk stratification: a debate","volume":"283","author":"Barter","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib7","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib8","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux","volume":"46","author":"Asztalos","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2760(93)90253-6","article-title":"Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations","volume":"1169","author":"Asztalos","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","article-title":"Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?","volume":"15","author":"Shao","year":"2018","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MOL.0000000000000612","article-title":"High-density lipoprotein: our elusive friend","volume":"30","author":"Asztalos","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib17","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14789450.2019.1650645","article-title":"Deepening our understanding of HDL proteome","volume":"16","author":"Ronsein","year":"2019","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/bi00401a005","article-title":"Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein","volume":"27","author":"Castro","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0005-2760(93)90254-7","article-title":"Comparison of apo A-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space","volume":"1169","author":"Asztalos","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.20.12.2670","article-title":"Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease","volume":"20","author":"Asztalos","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib22","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.ATV.0000146325.93749.a8","article-title":"High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study","volume":"24","author":"Asztalos","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib23","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/01.ATV.0000183727.90611.4f","article-title":"Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial","volume":"25","author":"Asztalos","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.ATV.0000066133.32063.BB","article-title":"Change in alpha 1 HDL concentration predicts progression in coronary artery stenosis","volume":"23","author":"Asztalos","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018381","article-title":"Levels of prebeta-1 high-density lipoprotein are a strong independent positive risk factor for coronary heart disease and myocardial infarction: a meta-analysis","volume":"10","author":"Pullinger","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2022.02.012","article-title":"The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity","volume":"345","author":"Asztalos","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1194\/jlr.RA119000258","article-title":"Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality","volume":"61","author":"Niisuke","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc19-0772","article-title":"High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes","volume":"43","author":"Vaisar","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib29","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1021\/acs.jproteome.1c00429","article-title":"Reproducible determination of high-density lipoprotein proteotypes","volume":"20","author":"Goetze","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100307","article-title":"HDL isolated by immunoaffinity, ultracentrifugation, or precipitation is compositionally and functionally distinct","volume":"63","author":"Holzer","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1194\/jlr.D061432","article-title":"Multiple apolipoprotein kinetics measured in human HDL by high-resolution\/accurate mass parallel reaction monitoring","volume":"57","author":"Singh","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib32","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/s41467-018-07454-w","article-title":"Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry","volume":"9","author":"Searle","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1194\/jlr.M600403-JLR200","article-title":"Role of LCAT in HDL remodeling: investigation of LCAT deficiency states","volume":"48","author":"Asztalos","year":"2007","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib34","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/ATVBAHA.118.311607","article-title":"Distinct proteomic signatures in 16 HDL (High-Density lipoprotein) subspecies","volume":"38","author":"Furtado","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib35","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.120.317178","article-title":"Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles","volume":"127","author":"He","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib36","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192616","article-title":"Type 2 diabetes is associated with loss of HDL endothelium protective functions","volume":"13","author":"Vaisar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fphar.2015.00243","article-title":"HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications","volume":"6","author":"Levkau","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.kint.2017.05.020","article-title":"Kidney function is associated with an altered protein composition of high-density lipoprotein","volume":"92","author":"Rubinow","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib42","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1021\/bi100359f","article-title":"Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation","volume":"49","author":"Cheung","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib43","article-title":"The HDL Proteome Watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ab.2011.06.032","article-title":"Assessment of an ad hoc procedure for isolation and characterization of human albuminome","volume":"418","author":"Scumaci","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2018.09.032","article-title":"High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography","volume":"278","author":"Gordon","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-023-01004-2","article-title":"Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease","volume":"118","author":"Guillas","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib47","article-title":"Protein-based HDL subspecies: rationale and association with cardiovascular disease, diabetes, stroke, and dementia","volume":"1867","author":"Sacks","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib48","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (High-Density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib49","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","article-title":"High-density lipoprotein subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts","volume":"137","author":"Jensen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98045","article-title":"Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk","volume":"3","author":"Morton","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep19249","article-title":"Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: \"Herniated\" HDL, a common feature in diabetes","volume":"6","author":"Amigo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.774418","article-title":"Cholesterol efflux capacity and its association with adverse cardiovascular events: a systematic Review and meta-analysis","volume":"8","author":"Lee","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib53","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1194\/jlr.M075382","article-title":"Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1","volume":"58","author":"Melchior","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1194\/jlr.M063701","article-title":"Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway","volume":"57","author":"Pamir","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib55","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1194\/jlr.M200429-JLR200","article-title":"A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins","volume":"44","author":"Thuahnai","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib56","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1021\/bi051029o","article-title":"SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux","volume":"44","author":"Chroni","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2024.118565_bib57","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/ATVBAHA.121.316278","article-title":"Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects","volume":"41","author":"Ronsein","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:55:28Z","timestamp":1727704528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":57,"alternative-id":["S0021915024011377"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118565","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships between HDL subpopulation proteome and HDL function in overweight\/obese people with and without coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118565"}}